Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Steve Glover Insider Profile
4 Followers
Steve Glover, President Follow-on Biologics at Insmed, holds 85.00K shares in Ambrx Biopharma (Ticker: AMAM), holds 492.76K shares in ZyVersa Therapeutics (Ticker: ZVSA), holds 63.79K shares in PDS Biotechnology (Ticker: PDSB).
Steve Glover has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Steve Glover holds in companies
Most Profitable Insider Trade
The most profitable trade made by Steve Glover
Steve Glover's Trading History
Insmed
Apr 02, 2009
President Follow-on Biologics
Uninformative Buy
―
$9.66M
PDS Biotechnology
Jun 17, 2021
Director
Informative Buy
50.00K
$237.94K
ZyVersa Therapeutics
Dec 14, 2022
Chief Executive Officer, Director
Uninformative Buy
―
$3.15M
Ambrx Biopharma
Jun 09, 2023
―
Uninformative Buy
―
$2.38M
List of latest transactions for each holding click on a transaction to see Steve Glover's performance on stock
You May Also Like
Steve Glover insider profile FAQ
What is the percentage of profitable transactions made by Steve Glover?
The percentage of profitable transactions made by Steve Glover is ―.
What is the average return per transaction made by Steve Glover?
The average return per transaction made by Steve Glover is ―.
What stocks does Steve Glover hold?
Steve Glover holds: INSM, PDSB, ZVSA, AMAM stocks.
What was Steve Glover’s latest transaction?
Steve Glover latest transaction was an Uninformative Buy of ―.
What was Steve Glover's most profitable transaction?
Steve Glover’s most profitable transaction was an Informative Buy of PDSB stock on June 17, 2021. The return on the trade was -66.30%.
What is Steve Glover's role in Insmed?
Steve Glover's role in Insmed is President Follow-on Biologics.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.